LA JOLLA, Calif.–(BUSINESS WIRE)–Moores Cancer Center at UC San Diego Health, the Office of Industry Relations and Alexandria Real Estate today announced that the 18th annual Industry/Academia Next Generation Precision Oncology Symposium will be held […]
SAN DIEGO, Sept. 1, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the 2022 […]
SEATTLE–(BUSINESS WIRE)– #Bcell–Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I, the First Engineered B Cell Therapy to Enter into Clinical Trials Click here to view original post Click here to view […]
GERMANTOWN, Md., Sept. 1, 2022 /PRNewswire/ — Precigen, Inc. (NASDAQ: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, […]
For many years, startups spinning out of top-tier universities would leave Dallas-Fort Worth in favor of major life sciences hubs like Boston and San Francisco. But a recent increase in lab inventory and venture capital […]
Life sciences development giant Alexandria Real Estate Equities pulled out of a 600K SF development project in California, taking a $30M loss in the process, the company disclosed in a regulatory filing. The Pasadena, California-based real estate […]
The eye-popping gains came on a day when all the major U.S. stock indexes fell. Click here to view original post Click here to view original post
The supply of a plant-derived anti-cancer drug can finally meet global demand after a team of scientists from Denmark and the U.S. engineered yeast to produce the precursor molecules. Previously, obtaining one gram of the […]
© 2022 Biotech Networks, LLC
